SQSTM1 and Alzheimer disease: Interestingly, in accordance with its anti-inflammatory properties, p62-LAB treatment decreased the relative abundance of the family Erysipelotrichaceae, previously demonstrated to be increased with age in AD mice and with a positive correlation with a pro-inflammatory gut micro-environment.